Skip to Main Content

Good morning, everyone, and welcome to another working week, although it may not quite seem that way, if only because you most likely have not moved very much since waking this morning. Nonetheless, we hope the weekend respite provided some sort of respite from the deluge of headlines and anxieties afflicting our world. In any event, the time has come to assume what resembles the usual routine of online meetings and deadlines. So grab a cup of stimulation and get started. On that note, here are a few tidbits to help you along. Stay safe and stay in touch.

A recent $2 trillion relief package that lawmakers passed on Friday could mean drug pricing advocates might be waiting a long while for legislation, possibly until November, weeks after Election Day, STAT reports. Until now, late May was widely viewed as a final 2020 deadline for lawmakers to take action on key health policy issues, including legislation to lower the price of prescription drugs. “I think Nov. 30 is the new May 22,” says Ben Wakana, the executive director of the advocacy group Patients for Affordable Drugs Now.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!